Insmed Incorporated (NASDAQ:INSM) Q4 2025 Earnings Call Transcript
Operator: Thank you for standing by, and welcome to the Insmed Fourth Quarter and Full Year 2025 Financial Results Conference Call. [Operator Instructions] Thank you.
Insmed Inc (INSM)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Darwin Global Management Abhishek Trehan | 20,933,277 | $3,644,274,193 | +3% | 73.78% |
| 2. | Baker Bros. Advisors Julian Baker And Felix Baker | 6,592,746 | $1,147,401,514 | -2% | 6.72% |
| 3. | D E Shaw D. E. Shaw | 4,350,995 | $757,247,170 | -24% | 0.42% |
| 4. | Orbis Investment Management William B. Gray | 4,179,957 | $727,479,716 | +29% | 3.05% |
| 5. | Millennium Management Israel Englander | 1,311,654 | $228,280,262 | -44% | 0.1% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $66.35 | 1,130 | $74,975.50 | 3,025 | 2025-05-21 | Filing | |
| $66.87 | 1,895 | $126,718.65 | 1,895 | 2025-05-20 | Filing | |
| $19.29 | 10,000 | $192,900.00 | 10,000 | 2023-05-15 | Filing | |
| $19.29 | 10,000 | $192,900.00 | 298,615 | 2023-05-15 | Filing | |
| $17.70 | 10,000 | $177,000.00 | 15,900 | 2022-11-01 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $153.38 | 1,030 | $157,981.40 | 301,185 | 2026-02-19 | Filing | |
| $151.92 | 2,377 | $361,113.84 | 302,215 | 2026-02-19 | Filing | |
| $151.12 | 3,413 | $515,772.56 | 304,592 | 2026-02-19 | Filing | |
| $150.10 | 1,891 | $283,839.10 | 308,005 | 2026-02-19 | Filing | |
| $149.17 | 1,988 | $296,549.96 | 309,896 | 2026-02-19 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 23,199,512 | $4,037,643,311 | 0.25% | |
| 2. | 21,076,344 | $3,668,126,910 | 0.05% | |
| 3. | 15,065,052 | $2,621,921,693 | 0.04% | |
| 4. | 9,927,936 | $1,727,857,942 | 0.09% | |
| 5. | 5,201,744 | $905,311,526 | 0.03% |
News See All
Insmed (INSM) Poised for 2026 Upside With Potential $1.3B Arikayce Sales Boost, Roth/MKM Initiates Buy
Insmed Inc. (NASDAQ:INSM) ranks among billionaire Stanley Druckenmiller’s 10 best stock picks. On January 23, Roth/MKM began coverage of Insmed Inc.
Stanley Druckenmiller Stock Portfolio: 10 Best Stock Picks
Stanley Druckenmiller originally rose to prominence by managing George Soros' Quantum Fund, where he oversaw the $10 billion currency bet that "broke the Bank of England" in 1992.
Analyst Weighs Patent Cliff Risks Against Insmed’s (INSM) Growth Story
Insmed Inc. (NASDAQ:INSM) is among the best debt-free stocks to buy now.
12 Best Debt-Free Stocks to Buy Now
The growing reliance on debt to finance multi-billion-dollar artificial intelligence and AI-infrastructure investments has come under increasing scrutiny.
Jim Cramer Commented on These 21 S&P 500 and Nasdaq-100 Stocks
Jim Cramer, the host of Mad Money, told viewers on Monday that investors should prioritize owning high-quality stocks and holding onto them, instead of constantly jumping in and out of trades where prices...
Insmed (INSM) Rose Following Drug Approval
Carillon Tower Advisers, an investment management company, released its “Carillon Eagle Mid Cap Growth Fund” third-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Here’s What Lifted Insmed Incorporated (INSM) in Q3
Artisan Partners, an investment management company, released its “Artisan Small Cap Fund” third-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Approval of Brinsupri Lifted Insmed Incorporated (INSM) in Q3
Baron Funds, an investment management company, released its “Baron Health Care Fund” third-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Insmed Incorporated (NASDAQ:INSM) Q3 2025 Earnings Call Transcript
Operator: Thank you for standing by. My name is Kayla, and I will be your conference operator today. At this time, I'd like to welcome everyone to the Insmed Third Quarter 2025 Financial Results.
Hedge Fund Resource Center